To explore the significance of the CD133–DNMT1 interaction in CD133‐ reduced DNMT1 nuclear translocation, CD133+ glioma cells were expressed CD133 shRNA and either shRNA‐resistant wild‐type CD133 or shRNA‐resistant CD133(1–862) mutant. Here, DNMT1 is linked to central nervous system cancer.